Medpace Holdings, Inc.
Medpace Holdings, Inc. (MEDP) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · MEDP · as of Mar 31, 2025
Ownership Breakdown
596
Institutional Holders
▼ 3 vs Q4
$7.80B
Total Inst. Value
▼ $628.33M vs Q4
28.56M
Shares Outstanding
freeFloat 80.52%
25.60M
13F Shares Held
▲ 248,185 vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
MEDP largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK, INC. services-commercial physical & biological research | 2.69M | 8.85% | 8.85% | $819.04B | May 2, 2025 | ▼ 39.1K |
VANGUARD GROUP INC services-commercial physical & biological research | 2.53M | 8.34% | 8.34% | $771.96B | May 9, 2025 | ▼ 37.2K |
INVESCO LTD. services-commercial physical & biological research | 1.19M | 3.91% | 3.91% | $361.60B | May 12, 2025 | ▲ 102.0K |
WASATCH ADVISORS LP services-commercial physical & biological research | 829.5K | 2.73% | 2.73% | $252.73B | May 15, 2025 | ▼ 107.4K |
STATE STREET CORP services-commercial physical & biological research | 783.0K | 2.58% | 2.58% | $238.57B | May 15, 2025 | ▲ 3.2K |
MAWER INVESTMENT MANAGEMENT LTD. services-commercial physical & biological research | 696.2K | 2.29% | 2.29% | $212.13B | May 7, 2025 | NEW |
GEODE CAPITAL MANAGEMENT, LLC services-commercial physical & biological research | 668.2K | 2.20% | 2.20% | $203.64B | May 13, 2025 | ▲ 12.1K |
BESSEMER GROUP INC services-commercial physical & biological research | 582.3K | 1.92% | 1.92% | $177.41B | Apr 23, 2025 | ▲ 6.2K |
RENAISSANCE TECHNOLOGIES LLC services-commercial physical & biological research | 577.7K | 1.90% | 1.90% | $176.02B | May 14, 2025 | ▲ 24.1K |
AQR CAPITAL MANAGEMENT LLC services-commercial physical & biological research | 539.5K | 1.78% | 1.78% | $158.47B | May 15, 2025 | ▲ 59.4K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
26
Increased
+1.12M shares1
New Positions
first time holders22
Decreased
−702.6K shares0
Sold Out
fully exitedNet shares change (top 50)
+421.0K
+1.12M / −702.6K
Net new holders
+5
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
MEDP insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
8
Buy transactions
9
Sell transactions
0.89
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
EWALD STEPHEN P General Counsel & Corp. Secy. | May 28, 2026 | Sale | 16,349 | $450.00 | $7.36M | 20.3K | Form 4 ↗ |
Zander Dani S. director | May 15, 2026 | Award | 1,110 | $415.27 | $460.9K | 1.1K | Form 4 ↗ |
McCarthy Cornelius P. III director | May 15, 2026 | Award | 1,110 | $415.27 | $460.9K | 1.1K | Form 4 ↗ |
Kraft Robert O. director | May 15, 2026 | Award | 1,110 | $415.27 | $460.9K | 1.1K | Form 4 ↗ |
Gwadry-Sridhar Femida H. director | May 15, 2026 | Award | 1,110 | $415.27 | $460.9K | 1.1K | Form 4 ↗ |
DAVENPORT FRED B JR director | May 15, 2026 | Award | 1,110 | $415.27 | $460.9K | 1.1K | Form 4 ↗ |
Carley Brian T director | May 15, 2026 | Award | 1,110 | $415.27 | $460.9K | 1.1K | Form 4 ↗ |
Troendle August J. CEO | Apr 24, 2026 | Award | 20,000 | $410.54 | $8.21M | 20.0K | Form 4 ↗ |
EWALD STEPHEN P General Counsel & Corp. Secy. | Apr 24, 2026 | Award | 10,000 | $410.54 | $4.11M | 10.0K | Form 4 ↗ |
BURWIG SUSAN E Exec. VP, Operations | Apr 24, 2026 | Award | 10,000 | $410.54 | $4.11M | 10.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Medpace Holdings, Inc. (MEDP) is primarily owned by institutional investors, who hold approximately 89.7% of total shares outstanding. Company insiders own approximately 19.48%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Medpace Holdings, Inc. is BLACKROCK, INC., holding approximately 2.69 million shares — equal to 8.85% of outstanding shares — as of March 31, 2025.
A total of 596 institutional investors currently hold MEDP stock, with a combined institutional value of approximately $7.80 billion as of the most recent 13F filing period.
Frequently asked questions
MEDP ownershipMedpace Holdings, Inc. (MEDP) is primarily owned by institutional investors, who hold approximately 89.7% of shares. The largest shareholder is BLACKROCK, INC. with a 8.85% stake. Company insiders hold 19.48%. Data sourced from SEC Form 13F as of March 31, 2025.